NEW YORK (GenomeWeb) – The US Food and Drug Administration has for the first time approved a drug to be given based on the genomic features in cancer patients' tumors, instead of where the tumor occurs in their bodies.
NEW YORK (GenomeWeb) – The US Food and Drug Administration has for the first time approved a drug to be given based on the genomic features in cancer patients' tumors, instead of where the tumor occurs in their bodies.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.